@article{IR,
      author = {Raymond, Lauren M. and Korzun, Tetiana and Kardosh, Adel  and Kolbeck, Kenneth J. and Pommier, Rodney F. and Mittra,  Erik S.},
      url = {http://digitalcollections.ohsu.edu/record/9243},
      title = {A comprehensive review of the therapeutic options for  gastroenteropancreatic neuroendocrine tumors with a focus  on PRRT and its sequencing},
      publisher = {Oregon Health and Science University},
      abstract = {Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)  are the most common form of neuroendocrine neoplasia, but  there is no current consensus for the sequencing of  approved therapies, particularly with respect to peptide  receptor radionuclide therapy (PRRT). Surgical resection is  recognized as the only clinically curative measure for  GEP-NETs; however, given that these tumors have a  propensity to metastasize and the primary tumor may, in  some cases, be unresectable, various treatment options have  been introduced including PRRT. This review evaluates the  data supporting approved therapies for GEP-NETs and the  current recommendations for therapeutic sequencing with a  focus on PRRT and how sequencing might change with respect  to the increasing body of literature regarding PRRT  utilization.},
      number = {IR},
      doi = {https://doi.org/10.6083/ws859g38c},
      recid = {9243},
      address = {2021},
}